Dr Neil Murphy is a cancer epidemiologist in the Department of Epidemiology and Biostatistics at Imperial College, London. He received a BSc in Nutrition from King’s College London, and an MSc in Modern Epidemiology and PhD in Epidemiology from Imperial College London. Dr Murphy has a major interest in understanding the aetiological mechanisms underlying the development of cancer. He has recently begun a portfolio of research aimed at investigating the metabolic and endocrinological influences on colorectal cancer, and has taken the lead in analyses of data from European and U.S. prospective cohort studies, including the European Prospective Investigation into Cancer and Nutrition (EPIC), UK Biobank, Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, and the Women's Health Initiative (WHI).
et al., 2022, Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN, Gut, ISSN:0017-5749
et al., 2022, Circulating plasma phospholipid fatty acid levels and breast cancer risk in the Cancer Prevention Study-II Nutrition Cohort, International Journal of Cancer, Vol:151, ISSN:0020-7136, Pages:2082-2094
et al., 2022, Genome-wide interaction analysis of genetic variants with menopausal hormone therapy for colorectal cancer risk, Journal of the National Cancer Institute, Vol:114, ISSN:0027-8874, Pages:1135-1148
et al., 2022, Cigarette smoking and endometrial cancer risk: observational and mendelian randomization analyses, Cancer Epidemiology, Biomarkers &amp; Prevention, Vol:31, ISSN:1055-9965, Pages:OF1-OF10
et al., 2022, Prospective Associations of Hemoglobin A1c and c-peptide with Risk of Diabetes-related Cancers in the Cancer Prevention Study-II Nutrition Cohort, Cancer Research Communications, Vol:2, Pages:653-662